Rett syndrome

From WikiMD's Wellnesspedia


Rett Syndrome (RTT) is a genetic neurological disorder primarily affecting females, characterized by a progression of multiple impairments affecting language, motor skills, and growth. It typically manifests between 6 to 18 months of age. While symptoms and their severity can vary, common issues include language and coordination difficulties, repetitive movements, growth retardation, problems with walking, and a reduced head size. Seizures, scoliosis, and sleep disturbances are notable complications. Despite these challenges, individuals with Rett Syndrome can often live into middle age.

Etiology[edit | edit source]

Rett Syndrome is caused by a genetic mutation, specifically in the MECP2 gene on the X chromosome. The mutation is typically de novo, arising spontaneously rather than being inherited from parents, accounting for less than one percent of cases. As the mutation occurs on the X chromosome, the condition almost exclusively affects girls; boys with a similar mutation generally do not survive beyond infancy.[1]

Diagnosis[edit | edit source]

Diagnosis of Rett Syndrome is symptom-based and can be confirmed with genetic testing to detect the MECP2 mutation. The diagnostic criteria encompass postnatal deceleration of head growth, loss of acquired purposeful hand skills followed by repetitive movements, social engagement impairments, poorly coordinated gait, and severe language development deficits.[2]

Treatment and Management[edit | edit source]

While there is currently no cure for Rett Syndrome, symptom management is crucial to enhance the quality of life. Therapies include special education programs, physiotherapy, occupational therapy, speech therapy, and use of orthotic devices. Anticonvulsant medications can help manage seizures. Nutritional support is often necessary due to chewing and swallowing difficulties.[3]

Epidemiology[edit | edit source]

Rett Syndrome is a rare disorder, affecting approximately 1 in 8,500 females.[4]

History[edit | edit source]

Rett Syndrome was first described in 1966 by Andreas Rett, a Viennese pediatrician. His findings, initially published in German, did not receive global attention until 1983, when Swedish pediatrician Bengt Hagberg published an article in English and named the syndrome after Rett. The causative mutation in the MECP2 gene was discovered in 1999 by Lebanese-American physician Huda Zoghbi.[5]

Research Directions[edit | edit source]

While the current management of Rett Syndrome focuses on symptomatic treatment, recent advances in understanding the molecular pathogenesis have opened up possibilities for targeted therapeutics. Preclinical studies have indicated that the neurological dysfunction in Rett Syndrome might be reversible, paving the way for new strategies that could restore normal neuronal function.[6]

See Also[edit | edit source]

References[edit | edit source]

Rett syndrome Resources

Find a healthcare provider anywhere in the world quickly and easily!

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

WikiMD.png


WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!



Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD, Dr.T